Fresenius SE Income Statement

Health Care & Life Sciences » Healthcare Provision | Fresenius SE

Fresenius SE | Income Statement

Fiscal year is January-December. All values EUR Millions.

2013

2014

2015

2016

2017

2018

Sales/Revenue

20,545

23,459

27,995

29,471

33,886

33,530

Cost of Goods Sold (COGS) incl. D&A

14,002

16,404

19,088

19,974

23,425

23,712

Gross Income

6,543

7,055

8,907

9,497

10,461

9,818

SG&A Expense

3,665

4,012

4,994

5,228

6,082

5,603

EBIT

2,878

3,043

4,269

4,379

4,215

Unusual Expense

Non Operating Income/Expense

143

987

Interest Expense

634

730

868

678

848

685

Pretax Income

2,362

2,515

3,321

3,720

3,938

4,664

Income Tax

664

703

977

1,044

905

950

Consolidated Net Income

1,698

1,812

2,344

2,676

3,033

3,714

Net Income

988

1,070

1,386

1,560

1,814

2,027

Net Income After Extraordinaries

988

1,070

1,386

1,560

1,814

2,027

Net Income Available to Common

988

1,070

1,386

1,560

1,814

2,027

EPS (Basic)

1.84

1.98

2.55

2.86

3.27

3.65

Basic Shares Outstanding

536

540

544

546

554

556

EPS (Diluted)

1.83

1.96

2.53

2.83

3.25

3.63

Diluted Shares Outstanding

540

544

548

550

558

557

EBITDA

3,780

3,998

5,037

5,484

5,816

5,710

Non-Operating Interest Income

128

255

197

Minority Interest Expense

710

742

958

1,116

1,219

1,687

About Fresenius SE

View Profile

Address	Else-Kröner-Strasse 1 Bad Homburg Hessen 61352 Germany
Employees	-
Website	http://www.fresenius.de
Updated	07/08/2019
Fresenius SE & Co. KGaA is a global healthcare group, which engages in the provision of products, and services for dialysis, hospitals, and outpatient medical care. It operates through the following business segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate & Other. The Fresenius Medical Care segment is comprised of dialysis products, and healthcare services.

Fresenius SE | Income Statement

About Fresenius SE

StatInvestor